Level Biotechnology Inc. (TPEX:3118)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
32.90
+0.15 (0.46%)
Jan 22, 2026, 1:28 PM CST
2.17%
Market Cap1.06B
Revenue (ttm)753.30M
Net Income (ttm)80.78M
Shares Out32.45M
EPS (ttm)2.48
PE Ratio13.21
Forward PEn/a
Dividend1.80 (5.44%)
Ex-Dividend DateJun 12, 2025
Volume9,436
Average Volume18,245
Open32.85
Previous Close32.75
Day's Range32.85 - 33.15
52-Week Range29.50 - 34.70
Beta0.30
RSI43.06
Earnings DateMar 10, 2026

About Level Biotechnology

Level Biotechnology Inc. engages in marketing and distributing cell culture, immunology, and molecular biology products in Taiwan. It markets and distributes biomedical precision equipment. The company also provides services in the areas of mammalian and genetic toxicology, pharmacology, biocompatibility, and model animal production. In addition, it offers preclinical research services to the biotech, pharmaceutical, medical device, animal health, and agrichemical industries. The company was founded in 1989 and is headquartered in New Taipei Ci... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1989
Employees 132
Stock Exchange Taipei Exchange
Ticker Symbol 3118
Full Company Profile

Financial Performance

In 2024, Level Biotechnology's revenue was 731.35 million, an increase of 10.71% compared to the previous year's 660.61 million. Earnings were 64.81 million, an increase of 3.03%.

Financial Statements